Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Palbociclib plus letrozole in estrogen receptor-positive ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial
0
Authors
Mansoor Mirza
19 more
Mansoor Mirza
•
Line Bjørge
17 more
•
Jalid Sehouli
Published
December 9, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Gynecologic Oncology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Urology
Show all topics
DOI
10.1016/j.ygyno.2024.12.003
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Gynecologic Oncology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Urology
Show all topics
DOI
10.1016/j.ygyno.2024.12.003
License
CC-BY
